Overview
Phreesia, Inc., based in the United States, operates primarily in the healthcare technology sector. The company specializes in developing a patient intake management platform that streamlines the healthcare check-in process, aiming to improve both the operational efficiency for healthcare providers and the experience for patients. Key initiatives include offering tailored solutions that support patient registration, insurance verification, clinical support, and payment collection, integrating seamlessly with electronic health records. Phreesia's approach leverages automation and technology to handle administrative tasks, thereby enabling healthcare professionals to focus more on patient care. This strategic focus not only enhances practice management but also gathers insightful data that assist healthcare facilities in making informed business decisions.
Basic Stats
The share price of Phreesia, Inc. as of September 5, 2025 is $28.12 / share. This is a decrease of -11.18% from the prior week. The market cap (or net worth) of Phreesia, Inc. as of September 5, 2025 is $1,680.73 MM.
The Factor Analysis chart (below right) shows a view of Phreesia, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 1,680.73 MM |
| EV | 1,584.09 MM |
| Shares Out. | 59.77 MM |
| Earnings Date | |
| EPS (TTM) | -0.40 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 1.30 MM |
| Short Interest | 2.94 MM |
| Short Float | 5.53 % |
| Days to Cover | 2.19 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 9.46 % |
| Volatility (1 yr) | 0.49 |
| Beta | 1.13 |
| Sharpe Ratio (1 yr) | 0.11 |
| Sortino Ratio (1 yr) | 0.18 |
| PE Ratio | -69.88 |
| Price/Book | 5.64 |
| Price/TBV | 11.85 |
| Book/Market | 0.18 |
| EBIT/EV | -0.01 |
| EBIT(3yr avg)/EV | -0.06 |
| ROA | -0.07 |
| ROE | -0.10 |
| ROIC | -0.08 |
| CROIC | 0.05 |
| OCROIC | 0.17 |
| Implied Volatility | 46.64 % |
| Put/Call OI Ratio | 0.59 |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Phreesia, Inc. is $33.15. The forecasts range from a low of $29.29 to a high of $37.80. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Phreesia, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-25 | Piper Sandler | Overweight | Maintains | |
| 2023-01-05 | SVB Leerink | Outperform | Maintains | |
| 2023-01-04 | Needham | Buy | Maintains | |
| 2023-02-02 | Keybanc | Overweight | Maintains | |
| 2022-12-13 | Citigroup | Neutral | Buy | Upgrade |
| 2022-12-12 | Raymond James | Outperform | Maintains | |
| 2022-12-09 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2022-12-09 | RBC Capital | Sector Perform | Maintains | |
| 2022-10-13 | DA Davidson | Neutral | Initiate | |
| 2022-10-12 | DA Davidson | Neutral | Initiate | |
| 2022-09-16 | Keybanc | Overweight | Initiate | |
| 2022-09-08 | SVB Leerink | Market Perform | Maintains | |
| 2022-09-08 | RBC Capital | Sector Perform | Maintains | |
| 2022-09-08 | Guggenheim | Buy | Maintains | |
| 2022-09-08 | Canaccord Genuity | Buy | Maintains | |
| 2022-06-14 | Piper Sandler | Overweight | Maintains | |
| 2022-06-06 | RBC Capital | Sector Perform | Maintains | |
| 2022-06-06 | Raymond James | Outperform | Maintains | |
| 2022-06-03 | SVB Leerink | Market Perform | Maintains | |
| 2022-06-03 | JMP Securities | Market Outperform | Maintains | |
| 2022-06-03 | Guggenheim | Buy | Maintains | |
| 2022-06-03 | Citigroup | Neutral | Maintains | |
| 2022-06-03 | Baird | Outperform | Maintains | |
| 2022-04-14 | Guggenheim | Buy | Initiate | |
| 2022-04-07 | RBC Capital | Sector Perform | Maintains | |
| 2022-04-01 | Raymond James | Outperform | Maintains | |
| 2022-03-31 | SVB Leerink | Market Perform | Maintains | |
| 2022-03-31 | Needham | Buy | Maintains | |
| 2022-03-31 | JMP Securities | Market Outperform | Maintains | |
| 2022-03-31 | Citigroup | Neutral | Maintains | |
| 2022-03-31 | Canaccord Genuity | Buy | Maintains | |
| 2022-01-06 | SVB Leerink | Outperform | Market Perform | Downgrade |
| 2021-12-14 | Raymond James | Outperform | Maintains | |
| 2021-12-10 | SVB Leerink | Outperform | Maintains | |
| 2021-12-09 | RBC Capital | Sector Perform | Maintains | |
| 2021-12-09 | Needham | Buy | Maintains | |
| 2021-12-02 | Jefferies | Buy | Initiate | |
| 2021-09-03 | Raymond James | Outperform | Maintains | |
| 2021-09-02 | Needham | Buy | Maintains | |
| 2021-08-27 | Canaccord Genuity | Buy | Initiate | |
| 2021-07-13 | JMP Securities | Market Outperform | Initiate | |
| 2021-07-12 | Keybanc | Overweight | Maintains | |
| 2021-06-08 | Berenberg | Buy | Initiate | |
| 2021-04-01 | SVB Leerink | Outperform | Maintains | |
| 2021-03-31 | KeyBanc | Overweight | Maintains | |
| 2021-01-14 | Needham | Buy | Maintains | |
| 2020-12-10 | SVB Leerink | Outperform | Maintains | |
| 2020-12-09 | Needham | Buy | Maintains | |
| 2020-12-09 | KeyBanc | Overweight | Maintains | |
| 2020-12-04 | KeyBanc | Overweight | Maintains | |
| 2020-11-11 | Stephens & Co. | Overweight | Initiate | |
| 2020-10-27 | Needham | Buy | Initiate | |
| 2020-09-22 | DA Davidson | Buy | Initiate | |
| 2020-09-10 | SVB Leerink | Outperform | Maintains | |
| 2020-09-10 | Raymond James | Outperform | Maintains | |
| 2020-07-14 | Citigroup | Neutral | Initiate | |
| 2020-06-10 | Raymond James | Outperform | Maintains | |
| 2020-06-09 | KeyBanc | Overweight | Maintains | |
| 2020-05-20 | KeyBanc | Overweight | Maintains | |
| 2020-05-15 | Guggenheim | Buy | Initiate | |
| 2020-04-24 | Wells Fargo | Overweight | Maintains | |
| 2020-04-24 | RBC Capital | Sector Perform | Maintains | |
| 2020-04-24 | Raymond James | Outperform | Maintains | |
| 2020-04-24 | Baird | Outperform | Maintains | |
| 2020-04-21 | RBC Capital | Sector Perform | Initiate | |
| 2020-04-08 | Baird | Outperform | Maintains | |
| 2020-03-31 | KeyBanc | Overweight | Reiterate | |
| 2020-01-31 | KeyBanc | Overweight | Initiate | |
| 2020-01-09 | Cantor Fitzgerald | Overweight | Initiate | |
| 2019-12-20 | Raymond James | Outperform | Initiate | |
| 2019-10-11 | Baird | Outperform | Initiate | |
| 2019-08-13 | JP Morgan | Overweight | Initiate | |
| 2019-08-12 | Wells Fargo | Outperform | Initiate | |
| 2019-08-12 | Piper Jaffray | Overweight | Initiate | |
| 2019-07-23 | Chardan Capital | Buy | Initiate | |
| 2023-03-20 | Needham | Buy | Reiterate | |
| 2023-03-23 | RBC Capital | Sector Perform | Maintains | |
| 2023-03-23 | JMP Securities | Outperform | Maintains | |
| 2023-03-23 | Needham | Buy | Reiterate | |
| 2023-03-23 | DA Davidson | Neutral | Maintains | |
| 2023-03-29 | Guggenheim | Buy | Maintains | |
| 2023-04-12 | Stephens & Co. | Overweight | Initiate | |
| 2023-05-25 | Keybanc | Overweight | Overweight | Maintains |
| 2023-06-01 | JMP Securities | Market Outperform | Reiterate | |
| 2023-06-01 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-06-01 | Needham | Buy | Buy | Reiterate |
| 2023-06-01 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2023-06-02 | Baird | Outperform | Outperform | Maintains |
| 2023-06-06 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-09-12 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-03-18 | Baird | Outperform | Outperform | Maintains |
| 2023-09-08 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-12-07 | Keybanc | Overweight | Overweight | Maintains |
| 2023-12-07 | Raymond James | Outperform | Outperform | Maintains |
| 2024-03-15 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-03-15 | DA Davidson | Neutral | Neutral | Maintains |
| 2024-03-15 | Canaccord Genuity | Buy | Buy | Maintains |
| 2023-09-07 | Canaccord Genuity | Buy | Buy | Maintains |
| 2023-09-01 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2023-09-11 | Raymond James | Outperform | Outperform | Maintains |
| 2023-08-15 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-09-07 | Citigroup | Buy | Buy | Maintains |
| 2023-09-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-09-07 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-09-07 | Needham | Buy | Buy | Reiterate |
| 2023-12-06 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2023-12-06 | Needham | Buy | Buy | Maintains |
| 2024-05-31 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-05-31 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-05-31 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-01-18 | Needham | Buy | Buy | Reiterate |
| 2024-02-26 | Truist Securities | Buy | Initiate | |
| 2024-03-12 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-03-22 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2024-03-15 | Raymond James | Outperform | Outperform | Reiterate |
| 2024-03-15 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-03-15 | Needham | Buy | Buy | Reiterate |
| 2024-05-31 | Needham | Buy | Buy | Reiterate |
| 2024-01-03 | Barclays | Overweight | Initiate | |
| 2024-06-03 | Truist Securities | Buy | Buy | Maintains |
| 2024-03-21 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-03-21 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2024-07-11 | Keybanc | Overweight | Overweight | Maintains |
| 2024-07-01 | Truist Securities | Buy | Buy | Maintains |
| 2025-03-13 | Needham | Buy | Buy | Reiterate |
| 2024-09-06 | Truist Securities | Buy | Buy | Maintains |
| 2024-09-27 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-08-30 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2025-01-08 | Keybanc | Overweight | Overweight | Maintains |
| 2025-03-13 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-01-10 | Citigroup | Buy | Buy | Maintains |
| 2025-01-10 | Needham | Buy | Buy | Reiterate |
| 2025-05-29 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-12-10 | Needham | Buy | Buy | Reiterate |
| 2024-09-05 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-09-05 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-09-05 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2024-09-05 | DA Davidson | Buy | Buy | Maintains |
| 2024-09-05 | Needham | Buy | Buy | Reiterate |
| 2025-01-29 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-09-06 | Baird | Outperform | Outperform | Maintains |
| 2024-12-10 | JMP Securities | Market Outperform | Market Outperform | Reiterate |
| 2025-04-16 | Keybanc | Overweight | Overweight | Maintains |
| 2024-09-09 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-12-11 | Baird | Outperform | Outperform | Maintains |
| 2024-12-11 | Truist Securities | Buy | Buy | Maintains |
| 2025-05-29 | Truist Securities | Buy | Buy | Maintains |
| 2025-01-08 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2025-04-14 | DA Davidson | Buy | Buy | Maintains |
| 2025-08-27 | Mizuho | Outperform | Initiate | |
| 2025-09-05 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-09-05 | Needham | Buy | Buy | Maintains |
| 2025-07-14 | Keybanc | Overweight | Overweight | Maintains |
| 2025-09-05 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-09-03 | Stephens & Co. | Overweight | Overweight | Reiterate |
